Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repare Therapeutics Inc.

1.47
+0.01701.17%
Post-market: 1.470.00000.00%19:19 EDT
Volume:37.23K
Turnover:53.85K
Market Cap:62.92M
PE:-0.49
High:1.47
Open:1.43
Low:1.41
Close:1.45
Loading ...

Repare Therapeutics Strengthens Leadership with New Executive Appointment

TIPRANKS
·
03 Jun

Repare Therapeutics Reports $124.2M in Cash and Securities, Announces Strategic Partnership and Pipeline Advancements in Q1 2025 Results

Reuters
·
14 May

Repare Therapeutics Inc: Exploring Strategic Alternatives to Advance Clinical Stage Pipeline and Maximize Shareholder Value

THOMSON REUTERS
·
14 May

Repare Therapeutics Inc: Cash, Cash Equivalents, and Marketable Securities Are Sufficient to Fund Its Current Operational Plans Through 2027

THOMSON REUTERS
·
14 May

LifeSci Capital Keeps Their Hold Rating on Repare Therapeutics (RPTX)

TIPRANKS
·
02 May

Repare Therapeutics Inc. Enters Partnership with DCx Biotherapeutics to Out-License Discovery Platforms

Reuters
·
01 May

DCx Biotherapeutics Partners with Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates

Reuters
·
01 May

Repare Therapeutics Announces Out-Licensing of Its Discovery Platforms to Dcx Biotherapeutics

THOMSON REUTERS
·
01 May

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics

Business Wire
·
01 May

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

Business Wire
·
26 Apr

BRIEF-Repare Therapeutics - Steve Forte, Executive Vice President And Chief Financial Officer, Appointed As President, Chief Executive Officer And Director

Reuters
·
01 Apr

Repare Therapeutics Appoints Steve Forte as CEO to Succeed Lloyd Segal

MT Newswires Live
·
01 Apr

Repare Therapeutics Names Forte as President, CEO

Dow Jones
·
01 Apr

Repare Therapeutics- Exploring Strategic Alternatives and Partnerships Across Portfolio, Including for Lunresertib & Camonsertib

THOMSON REUTERS
·
01 Apr

Repare Therapeutics - Steve Forte, Executive Vice President and Chief Financial Officer, Appointed as President, Chief Executive Officer and Director

THOMSON REUTERS
·
01 Apr

Repare Therapeutics: Lloyd M. Segal Resigned as President, CEO and Director

THOMSON REUTERS
·
01 Apr

Repare Therapeutics Announces Leadership Transitions

Business Wire
·
01 Apr

What Makes Repare Therapeutics (RPTX) a New Buy Stock

Zacks
·
12 Mar

Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics

TIPRANKS
·
07 Mar

Repare Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
04 Mar